Article
Cloning, expression, and functional characterization of human cyclooxygenase-1 splicing variants: evidence for intron 1 retention.
The Journal of pharmacology and experimental therapeutics - 1 Dec 2005
Qin Ning, Zhang Sui-Po, Reitz Tasha L, Mei Jay M, Flores Christopher M
Abstract excerpt
Recently, a splicing variant of cyclooxygenase (COX)-1, arising via the retention of its intron 1, was identified in canine. It was called COX-3 and was reported to be differentially sensitive to inhibition by various nonsteroidal anti-inflammatory drugs (NSAIDs) as well as acetaminophen (Chandrasekharan et al., 2002). However, the existence of an orthologous splicing variant in human tissues has been questioned...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
